EFFICACY AND SAFETY OF LONG-ACTING BETA AGONISTS plus LONG ACTING MUSCARINIC ANTAGONISTS VS. LONG-ACTING BETA AGONISTS plus INHALED CORTICOSTEROIDS IN COPD: A META-ANALYSIS

被引：0
|
作者：
Villalobos, R. E. [1 ]
David-Wang, A. [1 ]
Magallanes, J. [1 ]
机构：
[1] Univ Philippines, Philippine Gen Hosp, Manila, Philippines
来源：
THORAX | 2016年 / 71卷
关键词：
D O I：
10.1136/thoraxjnl-2016-209333.199
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P56
引用
收藏
页码：A113 / A114
页数：6
相关论文
共 50 条
  • [21] Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
    Hernandez, Gimena
    Avila, Monica
    Pont, Angels
    Garin, Olatz
    Alonso, Jordi
    Laforest, Laurent
    Cates, Christopher J.
    Ferrer, Montserrat
    RESPIRATORY RESEARCH, 2014, 15
  • [22] Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting 132 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting 132 Agonists Plus Inhaled Corticosteroids
    Liao, Pei-An
    Pan, Sheng-Wei
    Chen, Chun-Yu
    Deng, Chung-Yeh
    Dong, Yaa-Hui
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 553 - 563
  • [23] Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
    Gimena Hernández
    Mónica Avila
    Àngels Pont
    Olatz Garin
    Jordi Alonso
    Laurent Laforest
    Christopher J Cates
    Montserrat Ferrer
    Respiratory Research, 15
  • [24] Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2 - agonists (LABA) for adults with asthma
    Kew, Kayleigh M.
    Evans, David J. W.
    Allison, Debbie E.
    Boyter, Anne C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (06):
  • [25] Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials
    Chen, Wang-Chun
    Huang, Chi-Hsien
    Sheu, Chau-Chyun
    Chong, Inn-Wen
    Chu, Kuo-An
    Chen, Yung-Che
    Tsai, Jong-Rung
    Lee, Cheng-Hung
    Wei, Yu-Feng
    RESPIROLOGY, 2017, 22 (07) : 1313 - 1319
  • [26] Characterization Of COPD Patients Treated With Inhaled Triple Therapy Containing Inhaled Corticosteroids [ics], Long-Acting Beta2-Agonists [laba], And Long-Acting Muscarinic Antagonists [lama] In The Uk
    Mullerova, H.
    Maskell, J.
    Meeraus, W. H.
    Galkin, D.
    Albers, F. C.
    Gait, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [27] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Eung Gu Lee
    Youlim Kim
    Yong Il Hwang
    Kwang Ha Yoo
    So Eun Lee
    Kyung Yoon Jung
    Doik Lee
    Yong Bum Park
    Chin Kook Rhee
    Scientific Reports, 13
  • [28] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Lee, Eung Gu
    Kim, Youlim
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Jung, Kyung Yoon
    Lee, Doik
    Park, Yong Bum
    Rhee, Chin Kook
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Management of Chronic Obstructive Pulmonary Disease: Insights into Patient Profile - Use of Inhaled Corticosteroids/Long-Acting β2-Agonists or Long-Acting β2-Agonists/Long-acting Muscarinic Antagonists
    Kishore, Nevin
    Moitra, Saibal
    Sircar, Mrinal
    INDIAN JOURNAL OF RESPIRATORY CARE, 2020, 9 (02) : 162 - 170
  • [30] Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
    Oba, Yuji
    Sarva, Siva T.
    Dias, Sofia
    THORAX, 2016, 71 (01) : 15 - 25
12345